facebook

Living With an Eye Freckle: Cancer Risk, Prognosis and When to Seek a Second Opinion

3 min read

Being told you have a pigmented lesion in the eye can be unsettling, but most lesions labelled “freckles” are benign. The important principle is that risk is not uniform: the likelihood of transformation is concentrated in lesions with validated risk features and/or documented change over time. ¹

For choroidal naevi, large clinical series show that transformation into melanoma occurs in a minority overall, with probability rising as risk factors accumulate. ¹ ² For many patients, the most helpful reassurance is not “it’s fine,” but a clear explanation of what has been measured, what risk features are absent, and exactly how follow-up will detect change early.

A second opinion is reasonable if:

  • The diagnosis is unclear (naevus vs indeterminate vs melanoma-suspect)
  • You were not offered baseline imaging
  • A lesion has risk features but no structured recall plan
  • Symptoms are dismissed without examination and imaging

Specialist ocular oncology centres see borderline lesions routinely and can clarify risk, confirm imaging interpretation, and advise on surveillance versus treatment. ³

References

  1. Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Archives of Ophthalmology. 2009;127(8):981-987. doi:10.1001/archophthalmol.2009.151. PMID: 19667334.
  2. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112(10):1784-1789. doi:10.1016/j.ophtha.2005.06.011. PMID: 16154197.
  3. Shields CL, Shields JA. Melanoma of the eye: revealing hidden secrets, one at a time. Clinical and Experimental Ophthalmology. 2015;43(8):734-749. doi:10.1111/ceo.12547. PMID: 26213399.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.